{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:04:04Z","timestamp":1792674244012,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018975","name":"Uka Tarsadia University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018975","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejpb.2026.115131","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:01:09Z","timestamp":1780531269000},"page":"115131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["In situ nasal gel loaded with Lactoferrin-Coated Brexpiprazole nanostructured lipid carriers for Schizophrenia: Cross-Species validation in Ketamine-Induced rat and zebrafish models"],"prefix":"10.1016","volume":"226","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2947-9085","authenticated-orcid":false,"given":"Jaimini","family":"Parmar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehangi","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7036-5011","authenticated-orcid":false,"given":"Alkesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3575-6671","authenticated-orcid":false,"given":"Nimeet","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1057-2566","authenticated-orcid":false,"given":"Pranav","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2026.115131_b0005","doi-asserted-by":"crossref","unstructured":"S. Rakitzi, Schizophrenia, in: Clinical Psychology and Cognitive Behavioral Psychotherapy, Springer International Publishing, Cham, 2023: pp. 165\u2013188. Doi:10.1007\/978-3-031-27837-2_19.","DOI":"10.1007\/978-3-031-27837-2_19"},{"key":"10.1016\/j.ejpb.2026.115131_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2025.1629032","article-title":"Results of the Global Burden of Disease study for schizophrenia: trends from 1990 to 2021 and projections to 2050","volume":"16","author":"Zhan","year":"2025","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.ejpb.2026.115131_b0015","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.2147\/PPA.S430083","article-title":"Investigating the effect of Adherence to Antipsychotic Therapy on the Length of Stay and Number of Hospitalizations in patients with Schizophrenia \u2013 a Descriptive Analysis","volume":"17","author":"Barliana","year":"2023","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.ejpb.2026.115131_b0020","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41467-017-00716-z","article-title":"Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors","volume":"8","author":"Sykes","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejpb.2026.115131_b0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40263-013-0054-1","article-title":"Antipsychotic-Induced Metabolic and Cardiovascular Side Effects in Schizophrenia: a Novel Mechanistic Hypothesis","volume":"27","author":"Scigliano","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejpb.2026.115131_b0030","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2147\/NDT.S539306","article-title":"Brexpiprazole in the Management of Schizophrenia: a Consensus Report of best Practices from Acute to Maintenance Treatment","volume":"21","author":"Correll","year":"2025","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.ejpb.2026.115131_b0035","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3390\/brainsci13030397","article-title":"Brexpiprazole\u2014Pharmacologic Properties and use in Schizophrenia and Mood Disorders","volume":"13","author":"Siwek","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.ejpb.2026.115131_b0040","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S2215-0366(25)00043-4","article-title":"Efficacy and safety of brexpiprazole in adolescents with schizophrenia: a multicountry, randomised, double-blind, placebo-controlled, phase 3 trial with an active reference","volume":"12","author":"Ward","year":"2025","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.ejpb.2026.115131_b0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/17425247.2024.2306138","article-title":"Blood\u2013brain barrier transporters: a translational consideration for CNS delivery of neurotherapeutics","volume":"21","author":"Ronaldson","year":"2024","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2026.115131_b0050","article-title":"The Nasal\u2013Brain Drug delivery Route: Mechanisms and applications to Central nervous System Diseases","volume":"6","author":"Qiu","year":"2025","journal-title":"MedComm (Beijing)."},{"key":"10.1016\/j.ejpb.2026.115131_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21691401.2017.1420073","article-title":"Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting","author":"Selvaraj","year":"2017","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.ejpb.2026.115131_b0060","doi-asserted-by":"crossref","first-page":"12343","DOI":"10.2147\/IJN.S497480","article-title":"Nose to Brain: Exploring the Progress of Intranasal delivery of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers","volume":"19","author":"Zheng","year":"2024","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejpb.2026.115131_b0065","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1007\/s12035-024-04378-z","article-title":"Molecular Characterization and Expression of Lactoferrin Receptor (LfR) in Different Regions of the Brain responding to Lactoferrin intervention","volume":"62","author":"Wang","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejpb.2026.115131_b0070","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.3390\/cells10071810","article-title":"A Review on Lactoferrin and Central nervous System Diseases","volume":"10","author":"Li","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ejpb.2026.115131_b0075","doi-asserted-by":"crossref","first-page":"7565","DOI":"10.1007\/s00289-025-05881-6","article-title":"Navigating into the paradigm of lactoferrin surface modified nanocarriers in the management of central nervous system disorders","volume":"82","author":"Desai","year":"2025","journal-title":"Polym. Bull."},{"key":"10.1016\/j.ejpb.2026.115131_b0080","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3390\/ph18050615","article-title":"Advancements in Nanocarrier Systems for Nose-to-Brain Drug Delivery","volume":"18","author":"Nguyen","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejpb.2026.115131_b0085","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.3390\/polym16233422","article-title":"In Situ Thermosensitive Mucoadhesive Nasal Gel Containing Sumatriptan: In Vitro and Ex Vivo evaluations","volume":"16","author":"Alshraim","year":"2024","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ejpb.2026.115131_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2025.114259","article-title":"Engineering poloxamer copolymers for in situ gelling systems: Structural, compositional, and functional modifications","author":"Sil","year":"2025","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.ejpb.2026.115131_b0095","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1080\/03639045.2019.1593434","article-title":"Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization, in vitro characterization, cell line studies and in vivo efficacy in schizophrenia","volume":"45","author":"Patel","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2026.115131_b0100","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s00289-021-03598-w","article-title":"Ali, In vitro appraisals and ex vivo permeation prospect of chitosan nanoparticles designed for schizophrenia to intensify nasal delivery","volume":"79","author":"Annu","year":"2022","journal-title":"Polym. Bull."},{"key":"10.1016\/j.ejpb.2026.115131_b0105","doi-asserted-by":"crossref","first-page":"16707","DOI":"10.1038\/s41598-025-00918-2","article-title":"Intranasal delivery of blackberry-loaded Chitosan nanoparticles for antipsychotic potential in Ketamine-induced schizophrenia in rats","volume":"15","author":"George","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2026.115131_b0110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1208\/s12249-026-03403-9","article-title":"Design, Optimization, and In Vitro Evaluation of Lactoferrin-Coated Brexpiprazole-Loaded Nanostructured Lipid Carriers for Brain Targeting","volume":"27","author":"Parmar","year":"2026","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2026.115131_b0115","doi-asserted-by":"crossref","unstructured":"K.M. Noorulla, M. Yasir, F. Muzaffar, R. S, M.M. Ghoneim, A.S. Almurshedi, A.J. Tura, S. Alshehri, T. Gebissa, S. Mekit, M.M. Ahmed, A. Zafar, Intranasal delivery of chitosan decorated nanostructured lipid carriers of Buspirone for brain targeting: Formulation development, optimization and In-Vivo preclinical evaluation, J. Drug Deliv. Sci. Technol. 67 (2022) 102939. Doi:10.1016\/j.jddst.2021.102939.","DOI":"10.1016\/j.jddst.2021.102939"},{"key":"10.1016\/j.ejpb.2026.115131_b0120","doi-asserted-by":"crossref","DOI":"10.2174\/0113816128378420250804145740","article-title":"Ibrutinib Loaded Nanostructured Lipid Carriers for the Management of Chronic Lymphocytic Leukemia: Synchronizing In Silico, In Vitro, and In Vivo Studies","volume":"31","author":"Patel","year":"2025","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejpb.2026.115131_b0125","first-page":"185","article-title":"Formulation","volume":"14","author":"Teixeira","year":"2022","journal-title":"Characterization, and Cytotoxicity Evaluation of Lactoferrin Functionalized Lipid Nanoparticles for Riluzole Delivery to the Brain, Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115131_b0130","first-page":"3664","article-title":"In vitro and in vivo assessment of diosmetin-loaded lactoferrin-modified liposomes for brain delivery in intracerebral hemorrhage therapy, Drug Deliv","volume":"15","author":"Gu","year":"2025","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejpb.2026.115131_b0135","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1021\/acsomega.5c07466","article-title":"Folate-Functionalized Polymeric Nanoparticles for 5-Fluorouracil delivery to Prostate Cancer: Physicochemical and In Vitro\/In Vivo Characterization","volume":"11","author":"Bhatt","year":"2026","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejpb.2026.115131_b0140","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3390\/gels9100817","article-title":"Lamotrigine-Loaded Poloxamer-based Thermo-Responsive Sol\u2013Gel: Formulation, In Vitro Assessment, Ex Vivo Permeation, and Toxicology Study","author":"Riaz","year":"2023","journal-title":"Gels 9"},{"key":"10.1016\/j.ejpb.2026.115131_b0145","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2174\/1573412918666220406123600","article-title":"Characteristics, Biological Activities, Synthesis, and Methods for the Determination of Brexpiprazole in Different Matrices","volume":"18","author":"Shrivastava","year":"2022","journal-title":"Curr. Pharm. Anal."},{"key":"10.1016\/j.ejpb.2026.115131_b0150","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.3390\/pharmaceutics15112521","article-title":"Tailoring Risperidone-Loaded Glycethosomal In Situ Gels using Box\u2013Behnken Design for Treatment of Schizophrenia-Induced Rats via Intranasal Route","volume":"15","author":"Abdallah","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115131_b0155","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1208\/s12249-017-0747-8","article-title":"Formulation and Evaluation of Thermoreversible In Situ Nasal Gels Containing Mometasone Furoate for Allergic Rhinitis","volume":"18","author":"Altunta\u015f","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2026.115131_b0160","first-page":"1985","article-title":"Development of Atomoxetine-Loaded NLC In Situ Gel for Nose-to-Brain delivery: Optimization","volume":"15","author":"Mohanty","year":"2023","journal-title":"In Vitro, and Preclinical Evaluation, Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115131_b0165","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ejpb.2014.08.015","article-title":"Preparation and in vitro characterization of thermosensitive and mucoadhesive hydrogels for nasal delivery of phenylephrine hydrochloride","volume":"88","author":"Xu","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115131_b0170","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/gels11020082","article-title":"Development and Characterization of In Situ Gelling Nasal Cilostazol Spanlastics","volume":"11","author":"Salamah","year":"2025","journal-title":"Gels"},{"key":"10.1016\/j.ejpb.2026.115131_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2025.104025","article-title":"Genistein-loaded nanostructured lipid carriers for intranasal brain delivery: Preparation, optimization, in-vitro evaluation, and amelioration of bioavailability","volume":"114","author":"Alruwaili","year":"2025","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115131_b0180","doi-asserted-by":"crossref","first-page":"45118","DOI":"10.1038\/s41598-025-32985-w","article-title":"Design and optimization of intranasal aripiprazole-loaded nanostructured lipid carriers for enhanced brain targeting in schizophrenia: in vitro and ex vivo evaluation","volume":"15","author":"Rahamathulla","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2026.115131_b0185","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jddst.2015.10.010","article-title":"Design and development of intranasal in situ gelling system of Midazolam hydrochloride using 32 full factorial design","volume":"30","author":"Patel","year":"2015","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115131_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.chphi.2026.101017","article-title":"Molecular docking and physicochemical characterisation of kaempferol-hydroxy propyl-\u03b2-cyclodextrin\u2013Inclusion complex","volume":"12","author":"Sahani","year":"2026","journal-title":"Chem. Phys. Impact"},{"key":"10.1016\/j.ejpb.2026.115131_b0195","doi-asserted-by":"crossref","unstructured":"M.H. Warsi, A. Ali, M.A. Mirza, Mohammad, A. Zafar, Md.A. Mujtaba, Design and evaluation of carnosic acid-loaded thermosensitive lipidic nanogels for nasal delivery: ex vivo permeation, nasal ciliotoxicity, and antioxidant assessment, 3 Biotech 15 (2025) 193. Doi:10.1007\/s13205-025-04367-6.","DOI":"10.1007\/s13205-025-04367-6"},{"key":"10.1016\/j.ejpb.2026.115131_b0200","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pharma.2024.09.002","article-title":"In vivo pharmacokinetic study of carmustine in rats after giving single-dose of carmustine API solution, flexible liposomes, in situ nasal gel, optimized flexible liposomes embedded in situ nasal gel, and marketed formulation","volume":"83","author":"Mali","year":"2025","journal-title":"Ann. Pharm. Fr."},{"key":"10.1016\/j.ejpb.2026.115131_b0205","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/03639045.2018.1526186","article-title":"Brain targeting of chitosan-based diazepam mucoadhesive microemulsions via nasal route: formulation optimization, characterization, pharmacokinetic and pharmacodynamic evaluation","volume":"45","author":"Ramreddy","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2026.115131_b0210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11011-011-9234-1","article-title":"Behavioral changes and mitochondrial dysfunction in a rat model of schizophrenia induced by ketamine","volume":"26","author":"de Oliveira","year":"2011","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejpb.2026.115131_b0215","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/FBP.0000000000000689","article-title":"Ketamine as a pharmacological tool for the preclinical study of memory deficit in schizophrenia","volume":"34","author":"Su\u00e1rez Santiago","year":"2023","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115131_b0220","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jpsychires.2014.12.012","article-title":"Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia","volume":"61","author":"Xu","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.ejpb.2026.115131_b0225","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.brainresbull.2018.03.006","article-title":"Involvement of GABAergic, BDNF and Nox-2 mechanisms in the prevention and reversal of ketamine-induced schizophrenia-like behavior by morin in mice","volume":"139","author":"Ben-Azu","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejpb.2026.115131_b0230","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s11064-022-03808-5","article-title":"Reversal and Preventive Pleiotropic Mechanisms involved in the Antipsychotic-like effect of Taurine, an Essential \u03b2-Amino Acid in Ketamine-Induced Experimental Schizophrenia in mice","volume":"48","author":"Ben-Azu","year":"2023","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejpb.2026.115131_b0235","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1124\/jpet.113.205997","article-title":"Pharmacological Profile of 2-Bromoterguride at Human Dopamine D2, Porcine Serotonin 5-Hydroxytryptamine 2A, and \u03b12C-adrenergic Receptors, and its Antipsychotic-like Effects in Rats","volume":"347","author":"Jantschak","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejpb.2026.115131_b0240","doi-asserted-by":"crossref","DOI":"10.1371\/currents.md.1e2bec4e78697b7b0ff80ea25a1d38be","article-title":"A Modified Wire Hanging Apparatus for Small Animal Muscle Function Testing","author":"Hoffman","year":"2016","journal-title":"PLoS Curr."},{"key":"10.1016\/j.ejpb.2026.115131_b0245","author":"Gallas-Lopes","year":"2025","journal-title":"Ketamine-Induced NMDA Receptor Hypofunction Alters Social and Locomotor Behavior in Adult Zebrafish"},{"key":"10.1016\/j.ejpb.2026.115131_b0250","first-page":"1689","volume":"14","author":"Widder","year":"2024","journal-title":"Identification of Potential Sepsis Therapeutic Drugs Using a Zebrafish Rapid Screening Approach"},{"key":"10.1016\/j.ejpb.2026.115131_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2024.108820","article-title":"Embryotoxicity of statins and other prescribed drugs with reported off-target effects on cholesterol biosynthesis","volume":"132","author":"Hartley","year":"2025","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.ejpb.2026.115131_b0260","doi-asserted-by":"crossref","unstructured":"N. Assad, W.L. Luz, M. Santos-Silva, T. Carvalho, S. Moraes, D.L.W. Pican\u00e7o-Diniz, C.P. Bahia, E. de J. Oliveira Batista, A. da Concei\u00e7\u00e3o Passos, K.R.H.M. Oliveira, A.M. Herculano, Acute Restraint Stress Evokes Anxiety-Like Behavior Mediated by Telencephalic Inactivation and GabAergic Dysfunction in Zebrafish Brains, Sci. Rep. 10 (2020) 5551. Doi:10.1038\/s41598-020-62077-w.","DOI":"10.1038\/s41598-020-62077-w"},{"key":"10.1016\/j.ejpb.2026.115131_b0265","doi-asserted-by":"crossref","unstructured":"J.M. Cachat, P.R. Canavello, S.I. Elkhayat, B.K. Bartels, P.C. Hart, M.F. Elegante, E.C. Beeson, A.L. Laffoon, W.A.M. Haymore, D.H. Tien, A.K. Tien, S. Mohnot, A. V. Kalueff, Video-Aided Analysis of Zebrafish Locomotion and Anxiety-Related Behavioral Responses, in: 2011: pp. 1\u201314. Doi:10.1007\/978-1-60761-953-6_1.","DOI":"10.1007\/978-1-60761-953-6_1"},{"key":"10.1016\/j.ejpb.2026.115131_b0270","doi-asserted-by":"crossref","DOI":"10.3390\/biom10091340","article-title":"Evaluation of the adverse Effects of Chronic Exposure to Donepezil (an Acetylcholinesterase Inhibitor) in Adult Zebrafish by Behavioral and Biochemical Assessments","volume":"10","author":"Audira","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejpb.2026.115131_b0275","doi-asserted-by":"crossref","first-page":"15081","DOI":"10.1038\/s41598-017-15374-w","article-title":"Establishing zebrafish as a model to study the anxiolytic effects of scopolamine","volume":"7","author":"Hamilton","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2026.115131_b0280","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041464","article-title":"Development of a Modified Three-Day T-maze Protocol for evaluating Learning and memory Capacity of Adult Zebrafish","volume":"21","author":"Ngoc Hieu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2026.115131_b0285","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.3390\/ph18101548","article-title":"Preliminary Data Regarding the Alleviating Effects of Haloperidol and Risperidone on the Short-Term memory and Associative Learning in a Zebrafish Model of Schizophrenia","volume":"18","author":"Lungu","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejpb.2026.115131_b0290","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.3390\/ijms25137098","article-title":"Nanostructure-Mediated Transport of Therapeutics through Epithelial Barriers","volume":"25","author":"Hansen","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2026.115131_b0295","first-page":"534","article-title":"Brain targeted lactoferrin coated lipid nanocapsules for the combined effects of apocynin and lavender essential oil in PTZ induced seizures, Drug Deliv","volume":"15","author":"Youssef","year":"2025","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejpb.2026.115131_b0300","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.3390\/molecules27144408","article-title":"Mechanism Study on Nanoparticle negative Surface Charge Modification by Ascorbyl Palmitate and its Improvement of Tumor Targeting Ability","volume":"27","author":"Li","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2026.115131_b0305","series-title":"Transmission Electron Microscopy Characterization of Nanomaterials","first-page":"243","article-title":"TEM for Characterization of Core-Shell Nanomaterials","author":"Wang","year":"2014"},{"key":"10.1016\/j.ejpb.2026.115131_b0310","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/jnt5030008","article-title":"Advanced Characterization and Sample Preparation strategies for Nanoformulations","volume":"5","author":"Nadkarni","year":"2024","journal-title":"Journal of Nanotheranostics"},{"key":"10.1016\/j.ejpb.2026.115131_b0315","first-page":"1601","article-title":"Core\u2013Shell PLGA Nanoparticles","volume":"14","author":"Kovshova","year":"2024","journal-title":"In Vitro Evaluation of System Integrity, Biomolecules"},{"key":"10.1016\/j.ejpb.2026.115131_b0320","first-page":"928","article-title":"Nanostructured Lipid Carriers made of \u03a9-3 Polyunsaturated Fatty Acids","volume":"12","author":"Hernando","year":"2020","journal-title":"In Vitro Evaluation of Emerging Nanocarriers to Treat Neurodegenerative Diseases, Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115131_b0325","doi-asserted-by":"crossref","unstructured":"P. Kumar, Y.S. Lakshmi, B. C., K. Golla, A.K. Kondapi, Improved Safety, Bioavailability and Pharmacokinetics of Zidovudine through Lactoferrin Nanoparticles during Oral Administration in Rats, PLoS One 10 (2015) e0140399. Doi:10.1371\/journal.pone.0140399.","DOI":"10.1371\/journal.pone.0140399"},{"key":"10.1016\/j.ejpb.2026.115131_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2025.103402","article-title":"On the formation and stability mechanisms of diverse lipid-based nanostructures for drug delivery","volume":"338","author":"Shah","year":"2025","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.ejpb.2026.115131_b0335","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1007\/s13197-020-04357-x","article-title":"Development of nanostructured lipid carrier (NLC) assisted with polysorbate nonionic surfactants as a carrier for l-ascorbic acid and Gold Tri.E 30","volume":"57","author":"Eh Suk","year":"2020","journal-title":"J. Food Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115131_b0340","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-5173(99)00442-1","article-title":"Determination of baseline human nasal pH and the effect of intranasally administered buffers","volume":"198","author":"Washington","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115131_b0345","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1021\/acs.langmuir.3c00088","article-title":"Engineering the Structure and Rheological Properties of P407 Hydrogels via reverse Poloxamer Addition","volume":"39","author":"White","year":"2023","journal-title":"Langmuir"},{"key":"10.1016\/j.ejpb.2026.115131_b0350","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2147\/IJN.S439181","article-title":"Recent advances in Intranasal Administration for Brain-Targeting Delivery: a Comprehensive Review of Lipid-based Nanoparticles and Stimuli-Responsive Gel Formulations","volume":"19","author":"Koo","year":"2024","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejpb.2026.115131_b0355","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijpharm.2017.10.029","article-title":"In vitro and preclinical assessment of an intranasal spray formulation of parathyroid hormone PTH 1\u201334 for the treatment of osteoporosis","volume":"535","author":"Williams","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115131_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.jciso.2024.100126","article-title":"Blending induced variations in Poloxamer\u2019s\/Pluronic\u2019s\u00ae gelation: Thermodynamic and rheological perspectives","volume":"16","author":"Qutub","year":"2024","journal-title":"JCIS Open"},{"key":"10.1016\/j.ejpb.2026.115131_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106897","article-title":"Mucoadhesive in situ nasal gel of amoxicillin trihydrate for improved local delivery: Ex vivo mucosal permeation and retention studies","volume":"202","author":"Mardikasari","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115131_b0370","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3390\/polym13060873","article-title":"Rheological and Textural Properties of Apple Pectin-based Composite Formula with Xanthan Gum Modification for Preparation of Thickened Matrices with Dysphagia-Friendly potential","volume":"13","author":"Yang","year":"2021","journal-title":"Polymers (basel)."},{"key":"10.1016\/j.ejpb.2026.115131_b0375","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41538-025-00550-4","article-title":"Locust bean gum improved the gelling properties of fish gelatin in acidic environments and its application in acid gel gummies","volume":"9","author":"Wu","year":"2025","journal-title":"npj Sci. Food"},{"key":"10.1016\/j.ejpb.2026.115131_b0380","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/scipharm89020025","article-title":"Olanzapine Loaded Nanostructured Lipid Carriers via High Shear Homogenization and Ultrasonication","volume":"89","author":"Ajiboye","year":"2021","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.ejpb.2026.115131_b0385","first-page":"531","article-title":"Development of a Nanostructured Lipid Carrier (NLC) by a Low-Energy Method","volume":"13","author":"Ortiz","year":"2021","journal-title":"Comparison of Release Kinetics and Molecular Dynamics Simulation, Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115131_b0390","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40005-017-0320-1","article-title":"Mechanisms of drug release from advanced drug formulations such as polymeric-based drug-delivery systems and lipid nanoparticles","volume":"47","author":"Son","year":"2017","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.ejpb.2026.115131_b0395","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1208\/s12249-022-02252-6","article-title":"Effect of Different Absorption Enhancers on the Nasal Absorption of Nalmefene Hydrochloride","volume":"23","author":"Zhang","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2026.115131_b0400","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.3390\/ijms26083861","article-title":"Transnasal PLGA Nanoparticles with Terpene Permeation Enhancers: Membrane Remodeling and Tight Junction Modulation for Enhanced Brain Drug delivery","volume":"26","author":"Zhang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2026.115131_b0405","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2017.1361900","article-title":"Intestinal surfactant permeation enhancers and their interaction with enterocyte cell membranes in a mucosal explant system","volume":"5","author":"Danielsen","year":"2017","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.ejpb.2026.115131_b0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116616","article-title":"Unveiling the potential of intranasal delivery of renin-angiotensin system drugs: Insights on the pharmacokinetics of irbesartan","author":"Gouveia","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115131_b0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2024.124731","article-title":"In-vivo pharmacokinetic study of ibrutinib-loaded nanostructured lipid carriers in rat plasma by sensitive spectrofluorimetric method using harmonized approach of quality by design and white analytical chemistry","volume":"321","author":"Prajapati","year":"2024","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.ejpb.2026.115131_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119326","article-title":"Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases","volume":"274","author":"Anthony","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.ejpb.2026.115131_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.dscb.2025.100210","article-title":"Ketamine-induced behavioral perturbations, redox imbalances, and neurotransmitter deficits in mice: the preventive and reversal neuromodulatory potential of diosmin as an antipsychotic","volume":"18","author":"Eneni","year":"2025","journal-title":"Brain Disord."},{"key":"10.1016\/j.ejpb.2026.115131_b0430","doi-asserted-by":"crossref","first-page":"171","DOI":"10.7324\/JAPS.2016.60527","article-title":"Evaluation of antipsychotic effect of methanolic extract of Ocimum sanctum leaves on laboratory animals","author":"Sharma","year":"2016","journal-title":"J. Appl Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115131_b0435","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1021\/acsbiomaterials.4c02282","article-title":"Intranasal Administrations of AP39-Loaded Liposomes Selectively deliver H2S to Neuronal Mitochondria to Protect Neonatal Hypoxia\u2013Ischemia by Targeting ERK1\/2 and Caspase-1","volume":"11","author":"Song","year":"2025","journal-title":"ACS Biomater Sci. Eng."},{"key":"10.1016\/j.ejpb.2026.115131_b0440","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1080\/10717544.2019.1636420","article-title":"Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson\u2019s disease","volume":"26","author":"Tang","year":"2019","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2026.115131_b0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2024.114696","article-title":"Deep learning dives: predicting anxiety in zebrafish through novel tank assay analysis","volume":"287","author":"Muralidharan","year":"2024","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejpb.2026.115131_b0450","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00213-021-05990-w","article-title":"The zebrafish (Danio rerio) anxiety test battery: comparison of behavioral responses in the novel tank diving and light\u2013dark tasks following exposure to anxiogenic and anxiolytic compounds","volume":"239","author":"Fontana","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejpb.2026.115131_b0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0335308","article-title":"Behavioural variability and repeatability in adult zebrafish (Danio rerio) using the novel tank dive test","volume":"20","author":"Johnson","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2026.115131_b0460","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1124\/jpet.114.213793","article-title":"Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine activity Modulator","volume":"350","author":"Maeda","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejpb.2026.115131_b0465","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1080\/13880209.2023.2209130","article-title":"Lantana camara leaf extract ameliorates memory deficit and the neuroinflammation associated with scopolamine-induced Alzheimer\u2019s-like cognitive impairment in zebrafish and mice","volume":"61","author":"Amoah","year":"2023","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.ejpb.2026.115131_b0470","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41398-021-01651-w","article-title":"Increased locomotor activity via regulation of GABAergic signalling in foxp2 mutant zebrafish\u2014implications for neurodevelopmental disorders","volume":"11","author":"L\u00fcffe","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ejpb.2026.115131_b0475","article-title":"Free and nanoencapsulated curcumin prevents scopolamine-induced cognitive impairment in adult zebrafish","volume":"66","author":"Coradini","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126001529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126001529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:44:14Z","timestamp":1790109854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126001529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":95,"alternative-id":["S0939641126001529"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115131","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In situ nasal gel loaded with Lactoferrin-Coated Brexpiprazole nanostructured lipid carriers for Schizophrenia: Cross-Species validation in Ketamine-Induced rat and zebrafish models","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115131"}}